Hematology/Oncology
Borghaei H, de Marinis F, Dumoulin D, Reynolds C, Theelen WSME, Percent I, Gutierrez Calderon V, Johnson ML, Madroszyk-Flandin A, Garon EB, He K, Planchard[...]
Lee J, Boas EF, Duran-Struuk R, Gaba R, Schachtschneider KM, Comin-Anduix B, Galic Z, Haile S, Bassir A, Chiang J. Pigs as clinically relevant models[...]
Ravi S, Shanahan MJ, Levitt B, Harris KM, Cole SW. Socioeconomic inequalities in early adulthood disrupt the immune transcriptomic landscape via upstream regulators. Sci Rep.[...]
Sepucha K, Rudkin A, Baxter-King R, Stanton AL, Wenger N, Vavreck L, Naeim A. Perceptions of COVID-19 Risk: How Did People Adapt to the Novel[...]
Llovet JM, Cappuyns S, Finn RS. HIMALAYA Overall Survival Prominence and Other Routes to the Peak-Reply. JAMA Oncol. 2024 Jan 11. doi: 10.1001/jamaoncol.2023.6271. Epub ahead[...]
Wu TC, Luterstein E, Neilsen BK, Goldman JW, Garon EB, Lee JM, Felix C, Cao M, Tenn SE, Low DA, Kupelian PA, Steinberg ML, Lee[...]
Friedman CF, D'Souza A, Bello Roufai D, Tinker AV, de Miguel M, Gambardella V, Goldman J, Loi S, Melisko ME, Oaknin A, Spanggaard I, Shapiro[...]
Seitz KP, Baclig NV, Stiller R, Chen A. Implementation of a Near-Peer Support Program to Improve Trainee Well-Being after Patient Safety Events. ATS Sch. 2023[...]
Pant S, Wainberg ZA, Weekes CD, Furqan M, Kasi PM, Devoe CE, Leal AD, Chung V, Basturk O, VanWyk H, Tavares AM, Seenappa LM, Perry[...]
Glaspy J, Bondarenko I, Krasnozhon D, Rutty D, Chen J, Fu Y, Wang S, Hou Q, Li S. Efbemalenograstim alfa not inferior to pegfilgrastim in[...]